Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase II Study of Sorafenib in Patients With Metastatic Renal Cell Carcinoma

NCT00496756 is registered in ClinicalTrials.gov with University of Nebraska as lead sponsor.

NCT NCT00496756
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00496756 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase II Study of Sorafenib in Patients With Metastatic Renal Cell Carcinoma
Lead sponsor
University of Nebraska
Phase
Phase 2
Overall status
Terminated
Start date
March 1, 2007
Completion date
April 25, 2014
Enrollment
14 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

kidney cancer